Boothbay Fund Management’s 4D Pharma PLC Warrant LBPSW Stock Holding History

Boothbay Fund Management’s Portfolio LBPSW Stock Details LBPSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-27,625	Closed	-$133K	–	2888
2022 Q1	$133K	Hold	27,625	–	–	﹤0.01%	2036
2021 Q4	$151K	Hold	27,625	–	–	﹤0.01%	1596
2021 Q3	$170K	Hold	27,625	–	–	﹤0.01%	1637
2021 Q2	$298K	Buy	27,625 +1,025	+4%	+$1.03K	0.01%	1287
2021 Q1	$315K	Buy	+26,600	New	+$33.3K	0.01%	1164

Other funds holding LBPSW

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Boothbay Fund Management's LBPSW Position: Q2 2022 in Review

Boothbay Fund Management sold out of 4D Pharma PLC Warrant (LBPSW) in Q2 2022, closing a stake of 27,625 shares — an estimated $133K sold.

Boothbay Fund Management first reported a position in LBPSW in Q1 2021 and held it in 5 quarters. The position peaked at $315K in Q1 2021. 4 funds tracked by Wall St. Rank hold LBPSW as of Q2 2022.

Boothbay Fund Management reported no remaining 4D Pharma PLC Warrant position as of Q2 2022 after selling out during the quarter.
Boothbay Fund Management sold 27,625 4D Pharma PLC Warrant shares in Q2 2022, an estimated $133K.
Boothbay Fund Management first reported a position in 4D Pharma PLC Warrant in Q1 2021 and held it in 5 quarters.
Boothbay Fund Management's 4D Pharma PLC Warrant position peaked at $315K in Q1 2021.
4 funds tracked by Wall St. Rank held 4D Pharma PLC Warrant as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.